A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants

An open-label, randomized, multi-center trial was conducted to compare the immunogenicity and safety of an indigenously developed tetravalent DTwP-Hib vaccine, Easyfour®-TT with a commercially available vaccine, Quadrovax®. A total of 244 infants in good health, aged 6–10 weeks, were randomized in a...

Повний опис

Бібліографічні деталі

Автори:	Lalitendu Mohanty, Sunil Sharma, Beauty Behera, Sachin Panwar, Charu Paliwal, Anit Singh, Anu Gupta, Deepak Chandra Chilkoti
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Taylor & Francis Group 2017-09-01
Серія:	Human Vaccines & Immunotherapeutics
Предмети:	combination dtwp-hib easyfour®-tt seroprotection tetravalent vaccine
Онлайн доступ:	http://dx.doi.org/10.1080/21645515.2017.1342020
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!